Baseline eosinophil level may be a predictive indicator for the effectiveness of dupilumab in patients with prurigo nodularis: A single-center, real-world prospective study

Affiliations

• ¹ Department of Dermatology, Xiangya Hospital, Central South University, Changsha, People's Republic of China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, People's Republic of China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People's Republic of China; Furong Laboratory, Changsha, People's Republic of China.
• ² Department of Dermatology, Xiangya Hospital, Central South University, Changsha, People's Republic of China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Xiangya Hospital, Central South University, Changsha, People's Republic of China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, People's Republic of China; Furong Laboratory, Changsha, People's Republic of China. Electronic address: xylijie@csu.edu.cn.